About the ABPI

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

For further information and background, please review:

  1. Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market, Office of Health Economics [commissioned by the ABPI and BioIndustry Association], published December 2017
  2. UK’s Exit from the European Union: Brexit Life Science Industry Coalition Position Paper, published December 2017
  3. Maintaining and growing the UK’s world leading Life Sciences sector in the context of leaving the EU, ABPI, BioIndustry Association and PWC, published September 2016

Media enquiries

+44 (0) 20 7747 7147​​